Gamma-Secretase as a Target for Treating Invasive Glioma
Author Information
Author(s): Wang Li, Rahn Jennifer J, Lun XueQing, Sun Beichen, Kelly John J. P, Weiss Samuel, Robbins Stephen M, Forsyth Peter A, Senger Donna L
Primary Institution: Department of Oncology, University of Calgary
Hypothesis
Is the p75 neurotrophin receptor (p75NTR) a critical regulator of glioma invasion?
Conclusion
Inhibiting the p75NTR processing with gamma-secretase inhibitors significantly reduces glioma invasion and prolongs survival in animal models.
Supporting Evidence
- 85% of glioblastoma multiforme specimens expressed p75NTR.
- Gamma-secretase inhibitors significantly reduced glioma cell migration and invasion.
- Animals treated with gamma-secretase inhibitors showed prolonged survival.
- p75NTR processing was observed in patient tumor specimens.
- Cleavage-resistant p75NTR constructs did not induce glioma invasion.
Takeaway
Scientists found that a protein called p75NTR helps brain tumors grow and spread, and blocking it can help treat these tumors.
Methodology
The study used in vitro and in vivo models to assess the role of p75NTR in glioma invasion and the effects of gamma-secretase inhibitors.
Potential Biases
Potential bias in the selection of glioma cell lines and patient samples.
Limitations
The study primarily focused on specific glioma cell lines and may not fully represent all glioma types.
Participant Demographics
The study included glioma patient specimens, with a focus on those expressing p75NTR.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website